Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Better U Ketamine Eligibility 2026: 10 Screening Red Flags, Who May Qualify, and the DEA Deadline That Could Change At-Home Access
Healthcare & PharmaceuticalAdvertorial

Better U Ketamine Eligibility 2026: 10 Screening Red Flags, Who May Qualify, and the DEA Deadline That Could Change At-Home Access

August 5, 2026 11:05 PM

You saw an ad for Better U - maybe scrolling Facebook, maybe a friend going through something similar mentioned it - and "at-home ketamine therapy" caught your attention enough to bring you here. Before anything else: this is a paid advertorial, a commission may be earned through qualifying links in this article, and product claims belong to the brand, not this publication. Quick facts to know going in: Better U is an at-home, prescription...

Read more
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
Healthcare & PharmaceuticalCompany Update

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

August 5, 2026 10:15 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) supporting mFLUSIVA for adults 50 years of age and older. "The FDA approval of mFLUSIVA, our fourth...

Read more
DirectMax Review 2026: Men Ready to Move Beyond One-Ingredient ED Options Discover the 3-Active Sublingual Formula
Healthcare & PharmaceuticalAdvertorial

DirectMax Review 2026: Men Ready to Move Beyond One-Ingredient ED Options Discover the 3-Active Sublingual Formula

August 5, 2026 8:15 PM

Quick disclosure before you read further: This is a paid advertorial. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. DirectMax is marketed by Direct Meds as a prescription-only compounded medication. No FDA clearance or approval was confirmed for the compounded combination reviewed in this article, and this article does not independently...

Read more
Spring Lake Ranch's Expanded Programming Addresses Psychiatric Bed Shortage and Need for Additional Care Options
Healthcare & PharmaceuticalCompany Update

Spring Lake Ranch's Expanded Programming Addresses Psychiatric Bed Shortage and Need for Additional Care Options

August 5, 2026 6:55 PM

The Banks Transitional Living Program (Banks TLP) at Spring Lake Ranch has officially opened. This marks a significant expansion for the Ranch, which has provided farm-based clinical care for adults experiencing mental illness since 1932. Spring Lake Ranch's core therapeutic model combines robust mental health treatment with meaningful work in the Green Mountains of Vermont. Residents choose one of four specialties-farming, gardening,...

Read more
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
Healthcare & PharmaceuticalCompany Update

Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity

August 5, 2026 4:15 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the three and six months ended June 30, 2026. "Delivering 37% growth and achieving record year-over-year revenue for the 22nd consecutive quarter reflects continued execution across the business." said Larry...

Read more
Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Healthcare & PharmaceuticalEarnings

Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 5, 2026 4:05 PM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today reported financial results for the second quarter ended June 30, 2026 and provided a corporate update. "The second quarter of 2026 marked a defining growth phase for Protagonist with a successful commercial launch of ICOTYDE through our strategic partner and accelerating momentum across our internal R&D pipeline. ICOTYDE is quickly becoming a paradigm-shifting oral...

Read more
White Plains Center for Nursing Care Achieves CMS Overall Five-Star Quality Rating
Healthcare & PharmaceuticalAwards

White Plains Center for Nursing Care Achieves CMS Overall Five-Star Quality Rating

August 5, 2026 11:00 AM

White Plains Center for Nursing Care has been recognized with the Overall Five-Star Quality Rating from the Centers for Medicare & Medicaid Services (CMS), the highest overall rating awarded through CMS's Five-Star Quality Rating System. The recognition reflects the center's continued commitment to providing exceptional skilled nursing, rehabilitation, and long-term care services while maintaining the highest standards of quality and...

Read more
NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC
Healthcare & PharmaceuticalCompany Update

NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC

August 5, 2026 10:29 AM

NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID:MAJI), today announced that it has executed a definitive Letter of Intent (LOI) to acquire 100% of Xycota Biosciences, LLC ("Xycota"), a preclinical biotechnology platform engineering non-psychoactive, precision-targeted therapeutics to physically repair brain circuitry and restore synaptic connectivity. Xycota is advancing a transformative biological interface designed to physically repair...

Read more
Point of Freedom Opens Its Doors in Omaha, Offering Rapid-access Outpatient Recovery Led by People who Have Lived it
Healthcare & PharmaceuticalCompany Update

Point of Freedom Opens Its Doors in Omaha, Offering Rapid-access Outpatient Recovery Led by People who Have Lived it

August 5, 2026 10:00 AM

Jesse Rittenhouse once faced 10 years in prison and witnessed the collapse of everything he'd built. Brent Lambley once watched his four daughters placed in foster care while addiction ran his life into homelessness and violence across a 12-year stretch on the streets. Today, with nearly four decades in combined sobriety, the two of them run Point of Freedom, a new outpatient addiction treatment center in Omaha built on a conviction they earned...

Read more
Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets
Healthcare & PharmaceuticalProduct Announcements

Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets

August 5, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced the public launch of StrainScan Pro, an AI-powered visual intelligence platform initially focused on cannabis strain identification and analysis for dispensaries, with broader applications in agricultural quality control, food distribution, restaurants, and grocery supply-chain monitoring. StrainScan Pro leverages the Company's proprietary AI vision technology to deliver rapid,...

Read more
Becker Aesthetics & Plastic Surgery Highlights Personalized Approaches to Ethnic Rhinoplasty in Philadelphia
Healthcare & PharmaceuticalCompany Update

Becker Aesthetics & Plastic Surgery Highlights Personalized Approaches to Ethnic Rhinoplasty in Philadelphia

August 5, 2026 9:00 AM

Requests for ethnic rhinoplasty have grown as more patients look for nasal refinement that respects their cultural background rather than reshaping it toward a single ideal. AtBecker Aesthetics & Plastic Surgery, which serves patients in Philadelphia and the surrounding region, the facial plastic surgery team treats these procedures as highly individual. The goal is a nose that improves balance and supports comfortable breathing while keeping...

Read more
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
Healthcare & PharmaceuticalCompany Update

Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1

August 5, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that its wholly-owned subsidiary Napo Pharmaceuticals, Inc. (collectively, with Jaguar Health, Inc., "Jaguar") has satisfied the conditions required to receive payment of the non-dilutive $2 million holdback amount from Future Pak, LLC ("Future Pak") related to the U.S. commercial licensing agreement Jaguar entered in January 2026 with a Future Pak affiliate. As announced, Jaguar was...

Read more
Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
Healthcare & PharmaceuticalConferences

Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

August 5, 2026 8:45 AM

Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that management will host a booth at the Association of Diabetes Care & Education Specialists 2026 Annual Conference (the "Conference") in Columbus, Ohio, from August 7-10, 2026, where they will showcase the new Pivot tubeless...

Read more
Beyond the Clinical: How Social Workers Drive Kidney Transplant Success
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Beyond the Clinical: How Social Workers Drive Kidney Transplant Success

August 5, 2026 8:35 AM

While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it. The process can require rigorous medical, financial and emotional preparation. Clinical social workers help with this. In addition to guiding patients to successful transplantation, they help drive systemic efficiencies that can...

Read more
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
Healthcare & PharmaceuticalCompany Update

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

August 5, 2026 8:30 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that Tome Foundational Treatment, the Company's first direct-to-consumer skincare product, is planned to launch on August 25, 2026, with those on the waitlist getting early access to preorder. The launch of the Foundational Treatment represents a significant milestone in Dermata's strategic evolution toward...

Read more
Onsera Health Strengthens Cardiometabolic Care Delivery with Eli Lilly's(R) Oral GLP-1 Foundayo(R)
Healthcare & PharmaceuticalCompany Update

Onsera Health Strengthens Cardiometabolic Care Delivery with Eli Lilly's(R) Oral GLP-1 Foundayo(R)

August 5, 2026 7:00 AM

Onsera Health, a comprehensive, AI-driven cardiometabolic and weight management solution, announced that it is offering access to Eli Lilly's obesity management medications, Zepbound® (tirzepatide) and once-daily, oral, Foundayo, providing more optionality with FDA-approved GLP-1 treatments for adults living with obesity, overweight or weight-related cardiometabolic medical concerns. Through Onsera Health, eligible participants will be able to...

Read more
How T·TIME Is Bringing Dual-Action ED Treatment Below $6 Per Dose
Healthcare & PharmaceuticalProduct Announcements

How T·TIME Is Bringing Dual-Action ED Treatment Below $6 Per Dose

August 5, 2026 7:00 AM

T·TIME Health Inc., a Texas-based men's telehealth company, has launched OVERTIME, a physician-prescribed erectile dysfunction treatment designed around transparent pricing instead of hidden fees. While many online ED services advertise low starting prices, patients often discover additional physician fees, membership charges, platform costs, shipping fees, or other mandatory expenses before they can actually receive treatment. In many cases,...

Read more
Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed
Healthcare & PharmaceuticalCompany Update

Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed

August 5, 2026 3:20 AM

Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a leader in precision-based perioperative monitoring solutions, today announced that the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center has awarded a five-year national Non-Expendable Equipment (NX EQ) contract for quantitative neuromuscular monitoring to TrillaMed, LLC, the authorized U.S. federal distributor of the Senzime TetraGraph® system. The contract follows a competitive...

Read more
Keeps Powerhouse Reviews and Complaints: The Discreet 3-in-1 Prescription Option Men Seeking More Personalized Care May Wish They Found Sooner
Healthcare & PharmaceuticalAdvertorial

Keeps Powerhouse Reviews and Complaints: The Discreet 3-in-1 Prescription Option Men Seeking More Personalized Care May Wish They Found Sooner

August 4, 2026 9:20 PM

Advertorial Disclosure: This review contains affiliate links, so a commission may be earned from a qualifying transaction at no additional cost to the reader. Keeps operates the online platform, while a licensed clinician decides whether treatment is appropriate. Approval is not guaranteed, and this content is not medical advice. Review Current Keeps Powerhouse Pricing and Eligibility Keeps Powerhouse Reviews & Complaints 2026: "Scam or Legit?"...

Read more
Marijuana Industry Is Drowning In Confusion: Why Is Industry Now Demanding Hemp Standards It Never Applied to Itself
Healthcare & PharmaceuticalCompany Update

Marijuana Industry Is Drowning In Confusion: Why Is Industry Now Demanding Hemp Standards It Never Applied to Itself

August 4, 2026 6:20 PM

MMJ International Holdings today called on the cannabis industry to apply evenly the product integrity standards its own leaders are demanding of intoxicating hemp products - and said the April 2026 Marijuana Rescheduling Order granted federal medical classification to an entire category of state licensed products without requiring the evidence those standards exist to produce. During a recent Trade to Black discussion hosted by Anthony...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?